20:25:43 EST Fri 09 Dec 2022
Enter Symbol
or Name

Login ID:

Cannabis Summary for Nov. 21, 2022

2022-11-21 20:35 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index lost a fraction to 43.96, while the CSE Composite Index lost 6.83 to 269.55. South of the border, regulators in New York have approved the state's first recreational cannabis retailer licences, while also releasing draft market regulations.

The initial round of licences comes as part of New York's CAURD (conditional adult-use retail dispensary) program. This prioritizes "justice-involved" individuals -- those disproportionately affected by the war on drugs -- as well as non-profits with a record of helping those individuals. The state's Cannabis Control Board (CCB) has now approved retail licences for 28 individuals and eight non-profits, with more to come. They will be able to make the first recreational sales once the market launches later this year or next.

For non-CAURD-eligible applicants, which will have to wait until 150 CAURD licences are doled out before the CCB expands the applicant pool, today's focus was on the newly approved first draft of regulations. The 282-page package of rules covers various types of licences, from cultivation and processing to distribution and retail, along with guidelines on testing, packaging and enforcement. They will now undergo a 60-day public comment period.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2022 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.